- Country: Finland
- Summary: Lot 5: Tranexamic Acid 100 Mg/Ml (10 Ml, I.V., 1000 Mg Per Vial/Ampoule, Atc B02aa02)
- FIT Ref No: 109633409
- Deadline: 05 Dec 2024
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 670886-2024
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Tranexamic acid 100 mg/ml (10 ml, i.v., 1000 mg per vial/ampoule, ATC B02AA02) - Parenteral products (intravenous administration) - Active pharmaceutical ingredient: Tranexamic acid - Strength: 100 mg/ml - Pharmaceutical form: 10 ml, i.v., 1000 mg per vial/ampoule The minimum requirements of the Article is described in more detail in Annex 1.1. The delivery schedule for the articles is described in Annex 1. Quantity for the Article is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of June 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. The tender shall consist of one (1) Article. The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Doc Title: LOT 5: Tranexamic acid 100 mg/ml (10 ml, i.v.,... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLot 5: Tranexamic Acid 100 Mg/Ml (10 Ml, I.V., 1000 Mg Per Vial/Ampoule, Atc B02aa02) - Finland Tender
The FINNISH INSTITUTE FOR HEALTH AND WELFARE, a Government sector organization in Finland, has announced a new tender for Lot 5: Tranexamic Acid 100 Mg/Ml (10 Ml, I.V., 1000 Mg Per Vial/Ampoule, Atc B02aa02). This tender is published on FinlandTenders under FIT Ref No: 109633409 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-12-05.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
